On multivariate analysis including all differentially distributed baseline characteristics (NT‐proBNP, age, LVEF, haemoglobin, and coronary artery disease), in addition to age, LVEF, NT‐proBNP and haemoglobin levels, LOY ≥17%, but not the presence of DNMT3A/TET2 CHIP‐driver mutations remained a significant independent predictor of mortality during follow‐up (Figure 3A). Here, DNMT3A is linked to coronary artery disorder.